Literature DB >> 6221797

Characterisation of left ventricular collagen in the rat.

I Medugorac, R Jacob.   

Abstract

Collagen of the normal and hypertrophied rat left ventricle was successively extracted with neutral salt and dilute acid solutions, and pepsin digestion. The yield of dilute-acid soluble collagen was only 0.3 to 0.6% of total collagen; the solubility with neutral salt was even lower. Limited pepsin digestion permitted extraction of 50 to 65% of total collagen. The distribution of the various types of collagen molecules was analysed in pepsin-solubilised collagen in the presence of 3.6 mol . litre-1 urea with the aid of electrophoresis on polyacrylamide gels. In all samples of nonreduced and reduced left ventricular collagen of the rat, disc patterns of pepsin-soluble collagen revealed the occurrence of dimeric and trimeric components, as well as aggregates of higher molecular weight. Such observations suggest the presence of an extensive interchain and intermolecular cross-linking network. Electrophoretic analysis of nonreduced and reduced pepsin-solubilised collagen also revealed heterogeneity of left ventricular rat collagen due to its occurrence as a mixture of type I and type III collagen. The proportion of type I collagen molecule components was substantially higher than that of type III components in all investigated samples of rat left ventricular connective tissue. Postnatal growth, aging and myocardial hypertrophy may affect the ratio of type I to type III components.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221797     DOI: 10.1093/cvr/17.1.15

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  28 in total

Review 1.  Basic Biology of Extracellular Matrix in the Cardiovascular System, Part 1/4: JACC Focus Seminar.

Authors:  Gonzalo Del Monte-Nieto; Jens W Fischer; Daniel J Gorski; Richard P Harvey; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2020-05-05       Impact factor: 24.094

2.  Structural arrangement of the extracellular matrix network during myocardial development in the chick embryo heart.

Authors:  D Sanchez-Quintana; V Garcia-Martinez; D Macias; J M Hurle
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Cardiogel: a biosynthetic extracellular matrix for cardiomyocyte culture.

Authors:  W B VanWinkle; M B Snuggs; L M Buja
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

Review 4.  The extracellular matrix in myocardial injury, repair, and remodeling.

Authors:  Nikolaos G Frangogiannis
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

5.  The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat.

Authors:  R Pick; J E Jalil; J S Janicki; K T Weber
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

6.  Extracellular matrix arrangement in the papillary muscles of the adult rat heart. Alterations after doxorubicin administration and experimental hypertension.

Authors:  D Sanchez-Quintana; V Climent; V Garcia-Martinez; D Macias; J M Hurle
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

7.  Relation between regional echo intensity and myocardial connective tissue in chronic left ventricular disease.

Authors:  T R Shaw; R B Logan-Sinclair; C Surin; R J McAnulty; B Heard; G J Laurent; D G Gibson
Journal:  Br Heart J       Date:  1984-01

Review 8.  Mesenchymal stem cell-derived inflammatory fibroblasts mediate interstitial fibrosis in the aging heart.

Authors:  JoAnn Trial; Mark L Entman; Katarzyna A Cieslik
Journal:  J Mol Cell Cardiol       Date:  2015-12-22       Impact factor: 5.000

Review 9.  Intramyocardial fibroblast myocyte communication.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Circ Res       Date:  2010-01-08       Impact factor: 17.367

10.  Non-coordinate expression of collagen mRNAs during carbon monoxide-induced cardiac hypertrophy.

Authors:  D G Penney; L B Bugaisky
Journal:  Mol Cell Biochem       Date:  1992-01-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.